Diana DeGette

Clearly more needs to be done, such as advancing legislation I, Chairman Pallone, and others have introduced to tackle this public health priority.

The responsibility to protect young people from these dangerous products cannot fall solely on parents, teachers, and health officials.

This teen vaping epidemic is personal to me because in my State of Colorado, we have the highest percentage of teens vaping than anywhere.

In fact, one sophomore I talked to thinks that more than 60 percent of his peers are using e-cigarettes.

Simply put, our nation faces a youth vaping epidemic.

Congress continues to invest $1.5 billion in SAMHSA's state opioid response grants.

Looking forward, the Committee is focused on identifying ways to stem this crisis and bring relief to the millions of Americans who are suffering.

Given the complexity of the epidemic and its ability to evolve, states, federal government agencies, and Congress must remain vigilant.

The country is in the midst of an epidemic unlike any in recent history.

Today, the Committee continues its bipartisan efforts to combat the opioid crisis.

The crisis has continued to evolve, and the challenges that we face have continued to evolve along with it.

As we know, the country is in the midst of an epidemic unlike any in recent history.

Today, the subcommittee on Oversight and Investigations is holding a hearing entitled 'A Public Health Emergency: State Efforts to Curb the Opioid Crisis.'

Data challenges we identified in our 2008 report continue to make it difficult for FDA to accurately identify establishments subject to inspection.

I look forward to working with my colleagues to advance bipartisan reform that will actually lower drug prices.

This hearing should not be interpreted as an indictment of foreign drug manufacturing generally.

The year after that hearing, the world was reminded why securing the global pharmaceutical supply chain is critical, when it was discovered that tainted ingredients were used to produce heparin, which is a critical drug used in surgery and…

Because the FDA can't possibly test every new drug that comes into the U.S., inspections of drug manufacturers abroad are a critical way to ensure that manufacturers around the world are following quality standards and producing drugs that…

Today's hearing focuses on an area of longstanding concern to this committee that has taken on increased importance: The safety and effectiveness of pharmaceutical products made in foreign countries.

I think that'd be really helpful.

A necessary goal if we are to safeguard our planet and future generations from the devastating effects of climate change.

I am, frankly, very concerned by this implication that, since it is an international problem... we should somehow just sit around.

If saving the planet for our children and our grandchildren isn't enough, how about 21st century economic dominance?

We define American excellence and leadership in climate here in Congress, not by the terrible energy policies of China and India.

I have been trying to find a bipartisan cosponsor of this legislation that would be a market-based solution...